Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IMRIS (T.IM) down 4% in anticipation of Q4 year-end 2013 results

Gaalen Engen Gaalen Engen, .
0 Comments| February 28, 2014

{{labelSign}}  Favorites
{{errorMessage}}

IMRIS (TSX:IM, StockForum), a Winnipeg-based provider of image guided therapy solutions through its VISIUS Surgical Theatre, announced the date for its Q4 and year-end 2013 financial results conference call.

According to the news release, the conference call and webcast will take place on March 4, 2014 with a question and answer period for analysts and institutional investors to follow management's presentation.

There will also be a taped broadcast available to listeners until 12 a.m. on March 11, 2014 along with a live audio webcast available on the company's website.

IMRIS was in the news recently when the company received regulatory Australian clearance for its intraoperative CT solution.

Shares fell 7.54% on the news to $2.82 per share.

Currently there are 52.0m outstanding shares with a market cap of $146.7 million.



{{labelSign}}  Favorites
{{errorMessage}}